You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Alemtuzumab

Showing 51 - 75 of 419
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Immune Deficiency Disorders, Severe Combined Immunodeficiency, Chronic Granulomatous Disease Trial in Saint Louis (Transplant

Recruiting
  • Immune Deficiency Disorders
  • +13 more
  • Transplant preparative regimen of alemtuzumab, fludarabine, thiotepa, and melphalan
  • Saint Louis, Missouri
    Washington University
Apr 25, 2022

Idiopathic Pulmonary Fibrosis, Emphysema or COPD Trial in Pittsburgh (CD3/CD19 negative hematopoietic stem cells, Rituximab,

Recruiting
  • Idiopathic Pulmonary Fibrosis
  • Emphysema or COPD
  • CD3/CD19 negative hematopoietic stem cells
  • +6 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Long-term Immune Regulation Following Treatment With Lemtrada®.

Terminated
  • Multiple Sclerosis
  • Assessment of leukocyte function.
  • Los Angeles, California
    University of Southern California, Department of Neurology
Dec 15, 2020

Epidermolysis Bullosa Trial in Aurora, Chicago, New York (Palifermin, Fludarabine, Busulfan)

Terminated
  • Epidermolysis Bullosa
  • Aurora, Colorado
  • +2 more
Aug 13, 2021

Crohn's Disease Trial in Pittsburgh (autologous CD34-selected peripheral blood stem cells transplant, Alemtuzumab, ATG)

Recruiting
  • Crohn's Disease
  • autologous CD34-selected peripheral blood stem cells transplant
  • +8 more
  • Pittsburgh, Pennsylvania
  • +1 more
Feb 9, 2022

Aplastic Anemia Trial run by the NHLBI (Campath-1H, r-ATG, CsA)

Completed
Has Results
  • Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jul 2, 2021

Systemic Sclerosis, Diffuse Sclerosis Systemic, Interstitial Lung Disease Trial in Pittsburgh (Cyclophosphamide, Mesna,

Recruiting
  • Systemic Sclerosis
  • +3 more
  • Pittsburgh, Pennsylvania
  • +2 more
Dec 17, 2021

Leukemia, Erythroblastic, Acute, MDS Trial in New York (5-Azacytidine, Fludarabine, Melphalan)

Completed
Has Results
  • Leukemia, Erythroblastic, Acute
  • Myelodysplastic Syndromes
  • New York, New York
    Weill Cornell Medical College
Aug 25, 2021

Multiple Sclerosis Trial in Worldwide (Alemtuzumab (GZ402673))

Terminated
  • Multiple Sclerosis
  • Alemtuzumab (GZ402673)
  • New York, New York
  • +12 more
Apr 21, 2022

Acute Lymphoblastic Leukemia Trial in La Jolla, San Diego (Alemtuzumab, Clofarabine)

Terminated
Has Results
  • Acute Lymphoblastic Leukemia
  • La Jolla, California
  • +2 more
Jul 29, 2020

Sickle Cell Disease, Beta Thalassemia-Major Trial in New Hyde Park (alemtuzumab (Campath IH), Fludarabine, Melphalan)

Completed
Has Results
  • Sickle Cell Disease
  • Beta Thalassemia-Major
  • alemtuzumab (Campath IH)
  • +6 more
  • New Hyde Park, New York
    Cohen Children's Medical Center of New York
Jul 30, 2021

Severe Aplastic Anemia, Refractory, Severe Aplastic Anemia, Relapse Trial run by the NHLBI (Alemtuzumab (Campath ),

Completed
Has Results
  • Severe Aplastic Anemia, Refractory
  • Severe Aplastic Anemia, Relapse
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2020

Sickle Cell Disease, Stem Cell Transplant Complications, Red Blood Cell Disorder Trial in Calgary (Alemtuzumab, Total Body

Recruiting
  • Sickle Cell Disease
  • +3 more
  • Alemtuzumab
  • +2 more
  • Calgary, Alberta, Canada
    Alberta Children's Hospital
May 25, 2021

Sickle Cell Disease, GVHD Trial in United States (Diphenhydramine, Acetaminophen, Methylprednisolone)

Active, not recruiting
  • Sickle Cell Disease
  • Graft Versus Host Disease
  • Washington, District of Columbia
  • +6 more
Aug 4, 2021

B-cell Acute Lymphoblastic Leukemia Trial in France, United States (UCART22)

Recruiting
  • B-cell Acute Lymphoblastic Leukemia
  • UCART22
  • CLLS52
  • Los Angeles, California
  • +10 more
Sep 23, 2022

Inherited Immune Deficiencies Trial run by the NIAID (Campath 1H, Busulfan, Horse Anti-human Thymocyte Globulin (h-ATG))

Completed
Has Results
  • Inherited Immune Deficiencies
  • Campath 1H
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Apr 20, 2021

B-cell Chronic Lymphocytic Leukemia, Refractory Chronic Lymphocytic Leukemia, Stage 0 Chronic Lymphocytic Leukemia Trial in

Completed
Has Results
  • B-cell Chronic Lymphocytic Leukemia
  • +4 more
  • alemtuzumab
  • +9 more
  • Rochester, Minnesota
    Mayo Clinic
Jun 11, 2020

Leukemia Trial in Scottsdale, Rochester (Alemtuzumab, Rituximab, Sargramostim)

Completed
Has Results
  • Leukemia
  • Alemtuzumab
  • +2 more
  • Scottsdale, Arizona
  • +1 more
Mar 30, 2020

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in New York (Bendamustine, Carmustine, Etoposide)

Completed
Has Results
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • New York, New York
    Weill Cornell Medical College
Feb 1, 2021

Disorder Related to Renal Transplantation Trial in Madison (Campath-1H)

Terminated
Has Results
  • Disorder Related to Renal Transplantation
  • Madison, Wisconsin
    University of Wisconsin Hospital and Clinics
Aug 31, 2020

Relapsing Remitting Multiple Sclerosis Trial in Worldwide (alemtuzumab GZ402673)

Completed
Has Results
  • Relapsing Remitting Multiple Sclerosis
  • alemtuzumab GZ402673
  • Cullman, Alabama
  • +130 more
Mar 21, 2022

Relapsing Multiple Sclerosis, Relapsing Remitting Multiple Sclerosis, Secondary Progressive Multiple Sclerosis Trial in United

Recruiting
  • Relapsing Multiple Sclerosis
  • +2 more
  • Autologous Hematopoietic Stem Cell Transplantation
  • Best Available Therapy (BAT)
  • Palo Alto, California
  • +20 more
Jan 25, 2023

Allogeneic Hematopoietic Cell Transplantation Trial in Cincinnati (Alemtuzumab)

Completed
  • Allogeneic Hematopoietic Cell Transplantation
  • Alemtuzumab
  • Cincinnati, Ohio
    Cincinnati Children's Hospital Medical Center
Oct 3, 2019

Sickle Cell Disease Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Non-myeloablative haploidentical

Not yet recruiting
  • Sickle Cell Disease
  • Non-myeloablative haploidentical peripheral blood stem celltransplantation with briquilimab and abatacept
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Dec 4, 2023

Severe Aplastic Anemia Who Relapsed After Immunosuppressive

Active, not recruiting
  • Severe Aplastic Anemia
    • Bethesda, Maryland
      National Heart, Lung and Blood Institute (NHLBI)
    Apr 7, 2022